Mice treated with GL had smaller primary tumors and decreased lymph node metastases compared with mice treated with vehicle. »
04/16/15

Median OS of GBM and AA patients treated with (131)I-mABs reached 25.3 and 77.2 months, respectively, thus markedly exceeding that of historical controls. »
07/04/15

OTUB1 has a key role in genotoxic agent resistance. »
03/27/15

For ER+PR+ tumors, a positive association was seen between n-6 intake and breast cancer. »
04/02/15

ROS1 rearrangement was significantly associated with a higher risk of tumor recurrence (p=0.024). »
02/24/15

Results highlight the importance of specific cellular subsets in the metastatic process. »
07/05/15

Mechanistic analyses indicated that cortactin was able to activate the EGFR-ERK signaling pathway. »
04/27/15

Using single RT-PCR analyses a prognostic impact of miR-222 and miR-302c was detected. »
05/10/14

Treatment groups all showed significant inhibitory effects on SiHa cell growth, »
02/06/15

Biomarker candidates for DNA-methylation-based diagnostics of urothelial carcinoma. »
11/26/14